For-Robin
New York · Founded 2012
About For-Robin
For-Robin Therapeutics is an antibody immunotherapy company. The company name is in honor of Robin Quataert, the Founder’s sister, who died at age 31 of estrogen and progesterone receptor negative breast cancer. For-Robin’s primary mission is treating breast cancer patients. Our proprietary technology (the monoclonal antibody JAA-F11 and humanized variants of it) targets all breast cancer cell subtypes including triple negative breast cancer which currently has no targeted therapy.
Company Facts
- Founded: 2012
- Legal name: For-Robin, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.0M
- Last round: Grant (May 2015)
- Website: for-robin.com
- Phone: 7168293601
Social Profiles
Canonical: https://fsome.com/organization/for-robin-8344737 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.